Search |

Add/Edit My Facility

University of Michigan Medical School Hybridoma Core Facility

cite this facility

Primary Contact:

Elizabeth Smith

Last Updated: 05/19/2025

Facility RRID

RRID:SCR_027406

Facility Details

Core provides research services in custom monoclonal antibody development (mAb) and bulk production of monoclonal antibodies from established hybridomas (somatic cell hybrids). Core has developed monoclonal antibodies against a wide variety of lymphocyte surface antigens, tumor cell antigens, purified proteins, hormones, hormone receptors and recombinant proteins and peptides.